Tuesday, 17 November 2026European Markets

BIOSENIC Stock Bearish Momentum With A 32% Drop In The Last 21 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of BIOSENIC (BEL 20: BIOS.BR) fell by a staggering 32.53% in 21 sessions from €0.21 to €0.14 at 19:09 EST on Wednesday, after two successive sessions in a row of gains. BEL 20 is sliding 0.52% to €3,666.07, after two successive sessions in a row of gains.

About BIOSENIC

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.

Volume

Today's last reported volume for BIOSENIC is 90719 which is 92.34% below its average volume of 304183.

More news about BIOSENIC (BIOS.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 22 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›